COSCIENS Biopharma Inc. (CSCIF) Total liabilities 2016–2025
COSCIENS Biopharma Inc. (CSCIF) total liabilities at each fiscal year-end, per SEC filings.
$17.6MFY2025 · since FY2016: $25.4M → $17.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.6M | -19.7% |
| FY2024 | $21.9M | +708.5% |
| FY2023 | $2.7M | -32.5% |
| FY2022 | $4.0M | -93.1% |
| FY2021 | $58.2M | +144.5% |
| FY2020 | $23.8M | +6.0% |
| FY2019 | $22.4M | -2.9% |
| FY2018 | $23.1M | -7.5% |
| FY2017 | $25.0M | -1.8% |
| FY2016 | $25.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice